Osiris Therapeutics, Inc. to Present at 2012 UBS Global Life Sciences Conference

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today that C. Randal Mills, Ph.D., President and Chief Executive Officer, is scheduled to present at the 2012 UBS Global Life Sciences Conference on Thursday, September 20, 2012 at 2:30 p.m. ET in New York City.

Back to news